[
  {
    "ts": null,
    "headline": "DexCom Inc. stock outperforms competitors on strong trading day",
    "summary": "DexCom Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=c95ff1a4cd860df3871b6d2d2c53c45f2f77287f880121a015be69a9383c1c10",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758042000,
      "headline": "DexCom Inc. stock outperforms competitors on strong trading day",
      "id": 136811521,
      "image": "",
      "related": "DXCM",
      "source": "MarketWatch",
      "summary": "DexCom Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=c95ff1a4cd860df3871b6d2d2c53c45f2f77287f880121a015be69a9383c1c10"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street is Bullish on DexCom (DXCM), Here’s Why",
    "summary": "DexCom, Inc. (NASDAQ:DXCM) is one of the Best NASDAQ Stocks to Buy with Huge Upside Potential. Wall Street is bullish on DexCom, Inc. (NASDAQ:DXCM) after the company topped revenue and EPS estimates during its fiscal second quarter of 2025. The company posted $1.16 billion in revenue, up 15.21% year-over-year and ahead of consensus by $32.49 […]",
    "url": "https://finnhub.io/api/news?id=76c05186c3e6d420358211499ccad94709c8fe79af47038e07b771450bcc7944",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758040957,
      "headline": "Wall Street is Bullish on DexCom (DXCM), Here’s Why",
      "id": 136773849,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "DexCom, Inc. (NASDAQ:DXCM) is one of the Best NASDAQ Stocks to Buy with Huge Upside Potential. Wall Street is bullish on DexCom, Inc. (NASDAQ:DXCM) after the company topped revenue and EPS estimates during its fiscal second quarter of 2025. The company posted $1.16 billion in revenue, up 15.21% year-over-year and ahead of consensus by $32.49 […]",
      "url": "https://finnhub.io/api/news?id=76c05186c3e6d420358211499ccad94709c8fe79af47038e07b771450bcc7944"
    }
  },
  {
    "ts": null,
    "headline": "Insulet names new CFO; Dexcom CEO on leave",
    "summary": "Flavia Pease will take over as Insulet’s CFO on Sept. 30. Elsewhere, outgoing Dexcom CEO Kevin Sayer is taking a medical leave of absence.",
    "url": "https://finnhub.io/api/news?id=b3216ecadec11dae3881dddea73f8e9c0eb4ce0a0a8ae2e75808261061f1246b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758026203,
      "headline": "Insulet names new CFO; Dexcom CEO on leave",
      "id": 136773285,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Flavia Pease will take over as Insulet’s CFO on Sept. 30. Elsewhere, outgoing Dexcom CEO Kevin Sayer is taking a medical leave of absence.",
      "url": "https://finnhub.io/api/news?id=b3216ecadec11dae3881dddea73f8e9c0eb4ce0a0a8ae2e75808261061f1246b"
    }
  }
]